Abbott Laboratories (Pakistan) Limited (PSX:ABOT)

Market Cap	89.08B -14.0%
Revenue (ttm)	75.40B +10.6%
Net Income	7.97B +52.2%
EPS	81.37 +52.2%
Shares Out	97.90M
PE Ratio	11.18
Forward PE	10.14
Dividend	10.00 (1.10%)
Ex-Dividend Date	Apr 15, 2026

Volume	5,158
Average Volume	20,000
Open	929.90
Previous Close	924.46
Day's Range	902.02 - 938.00
52-Week Range	790.00 - 1,304.00
Beta	0.09
RSI	39.41
Earnings Date	Feb 20, 2026

About PSX:ABOT

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company engages in the manufacturing, importing, and marketing of branded generic pharmaceutical products; AND import and marketing of nutritional products. It imports and markets diagnostic equipment, molecu...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1888
• Employees: 1,406
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: ABOT

Financial Performance

In 2025, PSX:ABOT's revenue was 75.40 billion, an increase of 10.59% compared to the previous year's 68.18 billion. Earnings were 7.97 billion, an increase of 52.20%.